{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:42:28Z","timestamp":1792255348421,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-026-03843-1","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:05:52Z","timestamp":1792224352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical utility and impact of myocardial viability imaging with F-18 FDG positron emission tomography to predict left ventricular function improvement following revascularization in ischemic heart disease : a single center retrospective study"],"prefix":"10.1007","author":[{"given":"Muhammad Ahmad","family":"Qureshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthikeyan","family":"Ananthasubramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"3843_CR1","doi-asserted-by":"publisher","unstructured":"Yang L, Zheng B, Gong Y, Global (2025) regional and national burden of ischemic heart disease and its attributable risk factors from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021. BMC Cardiovasc Disord. ;25(1):625. https:\/\/doi.org\/10.1186\/s12872-025-05022-x PubMed PMID: 40841929; PubMed Central PMCID: PMC12372306","DOI":"10.1186\/s12872-025-05022-x"},{"issue":"7","key":"3843_CR2","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/s0735-1097","volume":"39","author":"KC Allman","year":"2002","unstructured":"Allman KC, Shaw LJ, Hachamovitch R, Udelson JE (2002) Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39(7):1151\u20131158. https:\/\/doi.org\/10.1016\/s0735-1097(02)01726-6 PubMed PMID: 11923039","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"3843_CR3","doi-asserted-by":"publisher","first-page":"e000053","DOI":"10.1161\/HCI.0000000000000053","volume":"13","author":"MJ Garcia","year":"2020","unstructured":"Garcia MJ, Kwong RY, Scherrer-Crosbie M, Taub CC, Blankstein R, Lima J et al (2020) State of the Art: Imaging for Myocardial Viability: A Scientific Statement From the American Heart Association. Circ Cardiovasc Imaging 13(7):e000053. 101161\/HCI.0000000000000053 PubMed PMID: 32833510","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"3843_CR4","first-page":"210","volume":"13","author":"RHJA Slart","year":"2006","unstructured":"Slart RHJA, Bax JJ, van Veldhuisen DJ, van der Wall EE, Dierckx RA, de Boer J et al (2006) Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol 13(2):210\u2013219 doi:10.1007\/BF02971245 PubMed PMID: 16580957","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol"},{"issue":"7","key":"3843_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cpcardiol.2007.04.001","volume":"32","author":"AFL Schinkel","year":"2007","unstructured":"Schinkel AFL, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH (2007) Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 32(7):375\u2013410. https:\/\/doi.org\/10.1016\/j.cpcardiol.2007.04.001 PubMed PMID: 17560992","journal-title":"Curr Probl Cardiol"},{"issue":"8","key":"3843_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1056\/NEJMoa1807365","volume":"381","author":"JA Panza","year":"2019","unstructured":"Panza JA, Ellis AM, Al-Khalidi HR, Holly TA, Berman DS, Oh JK et al (2019) Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. N Engl J Med 381(8):739\u2013748. https:\/\/doi.org\/10.1056\/NEJMoa1807365 PubMed PMID: 31433921; PubMed Central PMCID: PMC6814246","journal-title":"N Engl J Med"},{"issue":"15","key":"3843_CR7","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","volume":"387","author":"D Perera","year":"2022","unstructured":"Perera D, Clayton T, O\u2019Kane PD, Greenwood JP, Weerackody R, Ryan M et al (2022) Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction. N Engl J Med 387(15):1351\u20131360. 101056\/NEJMoa2206606 PubMed PMID: 36027563","journal-title":"N Engl J Med"},{"issue":"20","key":"3843_CR8","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.jacc.2007.09","volume":"50","author":"RSB Beanlands","year":"2007","unstructured":"Beanlands RSB, Nichol G, Huszti E, Humen D, Racine N, Freeman M et al (2007) F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 50(20):2002\u20132012. https:\/\/doi.org\/10.1016\/j.jacc.2007.09.006 PubMed PMID: 17996568","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"3843_CR9","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s10554-024-03252-2","volume":"40","author":"TH Schindler","year":"2024","unstructured":"Schindler TH, Valenta I, Dilsizian V (2024) Viability assessment in an evolving field of heart failure treatment: still needed? Int J Cardiovasc Imaging 40(9):1823\u20131825. https:\/\/doi.org\/10.1007\/s10554-024-03252-2 PubMed PMID: 39340722","journal-title":"Int J Cardiovasc Imaging"},{"issue":"5","key":"3843_CR10","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","volume":"23","author":"V Dilsizian","year":"2016","unstructured":"Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S et al (2016) ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol 23(5):1187\u20131226. https:\/\/doi.org\/10.1007\/s12350-016-0522-3 PubMed PMID: 27392702","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol"},{"issue":"4","key":"3843_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2967\/jnumed.109.065938","volume":"51","author":"A Abraham","year":"2010","unstructured":"Abraham A, Nichol G, Williams KA, Guo A, deKemp RA, Garrard L et al (2010) 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med Off Publ Soc Nucl Med 51(4):567\u2013574. https:\/\/doi.org\/10.2967\/jnumed.109.065938 PubMed PMID: 20237039","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"11","key":"3843_CR12","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1007\/s10554-025-03529-0","volume":"41","author":"Y Lu","year":"2025","unstructured":"Lu Y, Wang Y, Liu Z, Meng J, Yun M, Dong R et al (2025) Predict value of ratio of hibernating myocardium in TPD on reverse remodeling and MACEs in HFrEF patients post-revascularization. Int J Cardiovasc Imaging 41(11):2219\u20132228. https:\/\/doi.org\/10.1007\/s10554-025-03529-0 PubMed PMID: 41044300","journal-title":"Int J Cardiovasc Imaging"},{"issue":"1","key":"3843_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12968-014-0083","volume":"16","author":"S Glaveckaite","year":"2014","unstructured":"Glaveckaite S, Valeviciene N, Palionis D, Puronaite R, Serpytis P, Laucevicius A (2014) Prediction of long-term segmental and global functional recovery of hibernating myocardium after revascularisation based on low dose dobutamine and late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson 16(1):83. https:\/\/doi.org\/10.1186\/s12968-014-0083-z PubMed PMID: 25279683; PubMed Central PMCID: PMC4189152","journal-title":"J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson"},{"issue":"1","key":"3843_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jcmg.2023","volume":"17","author":"S Jain","year":"2024","unstructured":"Jain S, Jain A, Schindler TH (2024) Different Functional Outcome After Coronary Revascularization in Subacute and Chronic Hibernating Myocardium. JACC Cardiovasc Imaging 17(1):96\u201397. https:\/\/doi.org\/10.1016\/j.jcmg.202306.021 PubMed PMID: 37632501","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"3843_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12933-023-01970-w","volume":"22","author":"E Carluccio","year":"2023","unstructured":"Carluccio E, Biagioli P, Reboldi G, Mengoni A, Lauciello R, Zuchi C et al (2023) Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized controlled studies. Cardiovasc Diabetol 22(1):235. https:\/\/doi.org\/10.1186\/s12933-023-01970-w PubMed PMID: 37660005; PubMed Central PMCID: PMC10475184","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3843_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12933-025-02904-4","volume":"24","author":"I Leo","year":"2025","unstructured":"Leo I, Salerno N, Figliozzi S, Cersosimo A, Ielapi J, Stankowski K et al (2025) Effect of SGLT2 inhibitors on cardiac structure and function assessed by cardiac magnetic resonance: a systematic review and meta-analysis. Cardiovasc Diabetol 24(1):345. https:\/\/doi.org\/10.1186\/s12933-025-02904-4 PubMed PMID: 40841653; PubMed Central PMCID: PMC12372192","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3843_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/jcecho.jcecho_58_24","volume":"35","author":"MHA Sadek","year":"2025","unstructured":"Sadek MHA, Aboul-Saud MI, El Missiri AM, Abdellatif YAM (2025) Impact of Angiotensin Receptor-Neprilysin Inhibitor Therapy on Cardiac Remodeling in Patients with Heart Failure and Reduced Ejection Fraction. J Cardiovasc Echography 35(1):23\u201331. https:\/\/doi.org\/10.4103\/jcecho.jcecho_58_24 PubMed PMID: 40463763; PubMed Central PMCID: PMC12129276","journal-title":"J Cardiovasc Echography"},{"issue":"13","key":"3843_CR18","doi-asserted-by":"publisher","first-page":"e012272","DOI":"10.1161\/JAHA.119.012272","volume":"8","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhou R, Lu C, Chen Q, Xu T, Li D (2019) Effects of the Angiotensin-Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta-Analysis. J Am Heart Assoc 8(13):e012272. https:\/\/doi.org\/10.1161\/JAHA.119.012272 PubMed PMID: 31240976; PubMed Central PMCID: PMC6662364","journal-title":"J Am Heart Assoc"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-026-03843-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-026-03843-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-026-03843-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:02:53Z","timestamp":1792252973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-026-03843-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":18,"alternative-id":["3843"],"URL":"https:\/\/doi.org\/10.1007\/s10554-026-03843-1","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"29 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was reviewed and approved by the Institutional Review Board of Henry Ford Health. The requirement for informed consent was waived due to the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial disclosures or industry relationships to report.","order":2,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}